U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Quotables

"To place a man in a multi-stage rocket and project him into the controlling gravitational field of the moon where the passengers can make scientific observations, perhaps land alive, and then return to earth--all that constitutes a wild dream worthy of Jules Verne. I am bold enough to say that such a man-made voyage will never occur regardless of all future advances."

Lee deForest, American radio pioneer ; 1957

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Examiner: McGarry, Sean


Primary examiner statistics: 500 patents; average approval time: 500 days
Assistant examiner statistics: 125 patents; average approval time: 1007 days

Patents as Primary Examiner (view all)

Patent No. Patent Title:
8188059 Compounds and methods for modulating expression of GCGR
8188061 RNAi modulation of APOB and uses thereof
8188058 Use of toll-like receptor-9 agonists, toll-like receptor-4 antago...
8178507 Method for the modulation of function of transcription factors
8173612 Chemotherapy involving antisense oligonucleotides for preventing ...
8168606 RNAi inhibition of alpha-ENaC expression
8158597 Modulation of diacylglycerol acyltransferase 1 expression
8158598 Compositions and their uses directed to PTPR alpha
8153604 CNS-tumor treatment method and composition
8148344 Compositions and methods for mediating RNAi in vivo
8143233 RNA aptamers and methods for identifying the same
8143230 Compounds and methods for modulating expression of PCSK9
8138159 Composition for inhibiting function of human Flt3
8133874 Oligonucleotide or its functional homologue, a composition compri...
8119612 RNAi inhibition of alpha-ENaC expression
8114853 Methods of treating smooth muscle cell disorders
8110675 TP expression-inhibiting compound and siRNA sequence thereof
8110557 Gamma secretase inhibitor for treatment of herpesvirus infection
8110398 Stable cell lines and methods for evaluating gastrointestinal abs...
8105828 Stable cell lines and methods for evaluating gastrointestinal abs...
8106181 Methods for producing interfering RNA molecules in mammalian cell...
8093224 Antisense modulation of C-reactive protein expression
8084434 Runx2 isoforms in angiogenesis
8076306 Compositions and their uses directed to hepcidin
8076071 Methods for producing interfering RNA molecules in mammalian cell...
8071559 Compositions and methods for cancer diagnosis and treatment
8067385 Antiviral oligonucleotides targeting HBV
8067571 Antibacterial antisense oligonucleotide and method
8067386 Modulation of eIF4E-BP2 expression
8067575 RNA interference mediated inhibition of cyclin D1 gene expression...
8067389 Silencing of TGFβ type II receptor expression by siRNA
8067388 Decoy-containing pharmaceutical compositions and method of using ...
8063023 Impaired wound healing compositions and treatments
8039610 siRNA targeting superoxide dismutase 1 (SOD1)
8034789 Antisense compounds targeted to connexins and methods of use ther...
8034901 Bcl-G polypeptides, encoding nucleic acids and methods of use
8022046 Microsphere-based composition for preventing and/or reversing new...
8022198 siRNA targeting histamine receptor H1
8012947 Methods and compositions for promoting wound healing
8008471 Nucleic acids for inhibiting hairless protein expression and meth...

Patents as Assistant Examiner (view all)

Patent No. Patent Title:
6350581 Tumor-associated antigen
6331390 Cell-cycle regulatory proteins, and uses related thereto
6268137 Specific inhibitors of DNA methyl transferase
6258935 LSIRF polypeptides
6255071 Mammalian viral vectors and their uses
6245562 Identification of genes altered in multiple myeloma
6238918 DNA sequence encoding the tumor suppressor gene ING1
6218508 Anti-microbial proteins
6214545 Polymorphism analysis by nucleic acid structure probing
6190857 Diagnosis of disease state using MRNA profiles in peripheral leuk...
6190892 Microbial production of indigo
6187559 Phospholipase D gene
6187586 Antisense modulation of AKT-3 expression
6184348 Functional recombinantly prepared synthetic protein polymer
6177273 Antisense modulation of integrin-linked kinase expression
6174669 Method for making full-length cDNA libraries
6166182 Human neurotensin receptor type 2 and splice variants thereof
6165788 Antisense modulation of Survivin expression
6159946 Antisense inhibition of c-myc to modulate the proliferation of sm...
6159734 Antisense modulation of peroxisome proliferator-activated recepto...
6153595 Composition and method for treatment of CMV infections
6153404 Regulatory nucleotide sequence of the initiation of transcription
6143522 Methods of modulating apoptosis
6140492 Antisense transcript expressed in B lymphocytes and synthetic ...
6140042 TAB1 protein and DNA coding therefore
6140072 Functional recombinantly prepared synthetic protein polymer
6140112 Pharmaceutical compositions and their use, namely for the treatme...
6140126 Antisense modulation of Y-box binding protein 1 expression
6136547 Nucleic acid molecules encoding glutx and uses thereof
6136602 Oligonucleotides specific for the marORAB operon
6133242 Inhibition of extracellular matrix synthesis by antisense compoun...
6133024 Gene expression control
6132954 Methods of screening for agents that delay a cell cycle and compo...
6120993 5-oxoprolinase
6117633 DNA sequence encoding the tumor suppressor gene ING1
6110898 DNA vaccines for eliciting a mucosal immune response
6107478 Retroviral vector, a replication system for said vector and avian...
6107094 Oligoribonucleotides and ribonucleases for cleaving RNA
6107092 Antisense modulation of SRA expression
6107457 Bcr-Abl directed compositions and uses for inhibiting Philadelphi...
 
Sign InRegister
Username  
Password   
forgot password?